Natixis’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-411,839
Closed -$57.7M 1131
2020
Q3
$57.7M Buy
411,839
+373,313
+969% +$45.5M 0.42% 62
2020
Q2
$2.9M Buy
+38,526
New +$2.02M 0.02% 363

Natixis's LVGO Position: Q4 2020 in Review

Natixis sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 411,839 shares — an estimated $57.7M sold.

Natixis first reported a position in LVGO in Q2 2020 and held it in 2 quarters. The position peaked at $57.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Natixis reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Natixis sold 411,839 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $57.7M.
  • Natixis first reported a position in Livongo Health, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Natixis's Livongo Health, Inc. Common Stock position peaked at $57.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Natixis's 13F filing for Q4 2020, filed 12 Feb 2021.